Yibin Kang, a professor in the Department of Molecular Biology, discussed new breast cancer research in his lab.

Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor inhibitors in patients with mCRPC Entered into clinical trial co ...

The Broad Institute and Illumina today announced their intent to collaborate on a groundbreaking Spatial Flagship Project, ...

Over 18000 lives are lost to cancer every year according to the global cancer statistics. Breast and prostate cancers are the ...

The leading Advanced Melanoma Companies such as OncoSec Medical, Immunocore, Sanofi, TILT Biotherapeutics, Novartis ...

A new study tied eating at least 2 servings of yogurt per week to a lower risk of an aggressive type of colorectal cancer.

The leading Metastatic Pancreatic Cancer Companies such as Xencor, MEI Pharma, Celldex Therapeutics, TG Therapeutics, ...

With federal support, universities produce world-changing discoveries and the next generation of exquisitely well-trained ...

American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Panning for Gold: The Role of ctDNA as ...

Melbourne-based scientists have, for the first time, discovered how to "switch off" a molecule which is one of the top ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.